Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01084733 · ClinicalTrials.gov registry record
Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
A clinical trial of Oropharyngeal Cancer and Oral Cavity Cancer, sponsored by Mahesh Kudrimoti.
- Completed
- Registry status
- 115
- Enrollment target
- 1
- Study location
NCT01084733 is a study of Oropharyngeal Cancer and Oral Cavity Cancer that has completed, run by Mahesh Kudrimoti. The registered enrollment target is 115 participants, below the 185-participant average among 25 other Oropharyngeal Cancer trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01084733, a study of Oropharyngeal Cancer and Oral Cavity Cancer, has completed, sponsored by Mahesh Kudrimoti.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the relationship between serum nicotine levels and tumor response of squamous cell cancers of the head and neck (SCCHN) to radiotherapy alone or in combination with chemotherapy. Correlation of RECIST response, volumatic response, pathologic response (in patients receiving post-treatment neck dissection), and hemodynamic response (tumor oxygenation and blood flow) will be performed.
Conditions Studied
Study Locations (1)
Kentucky
- Markey Cancer Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2007-08 |
| Est. Completion | 2019-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01084733
The ClinicalTrials.gov registry entry for NCT01084733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 25 other Oropharyngeal Cancer trials with a reported enrollment target (38% lower). The listed sponsor is Mahesh Kudrimoti, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Oropharyngeal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01084733 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT01084733 about?
NCT01084733 is a clinical study titled "Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer". The objective of this study is to evaluate the relationship between serum nicotine levels and tumor response of squamous cell cancers of the head and neck (SCCHN) to radiotherapy alone or in combination with chemotherapy. Correlation of RECIST response, volumatic response, pathologic response (in p...
What is the current status of trial NCT01084733?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2007-08. Estimated completion is 2019-06-30.
What conditions does trial NCT01084733 study?
This clinical trial studies the following conditions: Oropharyngeal Cancer, Oral Cavity Cancer, Larynx Cancer, Lip Cancer, Pharyngeal Cancer.
Who is sponsoring clinical trial NCT01084733?
This trial is sponsored by Mahesh Kudrimoti, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01084733 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oropharyngeal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
RECRUITING
-
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
RECRUITING · Phase 2
-
BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
RECRUITING · Phase 2
-
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
RECRUITING · Phase 2
-
Liposomal Bupivacaine and Transoral Robotic Surgery
RECRUITING
-
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.